The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes

• Published in: Neurochemistry international 2012-01, Vol.60 (2), p.125-133
• Main Authors: Kim, Ha Na, Lee, Sook-Jeong, Koh, Jae-Young
• Format: Article
• Language: English
• Subjects: AKT protein; Animals; Astrocytes; Astrocytes - cytology; Astrocytes - drug effects; Astrocytes - metabolism; Autophagy - drug effects; Autophagy - physiology; Biological and medical sciences; Brain; Cell death; Cells, Cultured; Chelating agents; Confocal microscopy; Fundamental and applied biological sciences. Psychology; Humans; Huntingtin; Intracellular Zn2; Mice; Mutant huntingtin; Neurons - classification; Neurons - drug effects; Neurons - metabolism; Neuroprotective Agents - classification; Neuroprotective Agents - pharmacology; Neurosteroids; Phagocytosis; Pregnanolone; Pregnanolone - classification; Pregnanolone - pharmacology; Pregnenolone; Progesterone; Progesterone - classification; Progesterone - pharmacology; Steroids; TOR protein; Transmission electron microscopy; Vacuoles; Vertebrates: nervous system and sense organs; Western blotting; Zinc
• ISSN: 0197-0186; 1872-9754
• DOI: 10.1016/j.neuint.2011.11.015

► Neurosteroids activate functional autophagy without cell death in astrocytes. ► The concurrent activation of Akt and mTOR limits runaway autophagy activation. ► In neurosteroid-induced autophagy, increases in labile zinc levels play a key role. Recent studies have suggested that neurosteroids such as pregnenolone, progesterone (PG) and their derivatives, have a role in activating autophagy in addition to diverse other functions. In our previous studies, we demonstrated that cellular free Zn2+ is involved in oxidative stress-induced autophagy and autophagic cell death in astrocytes. In the present study, we examined the possibility that neurosteroids, allopregnanolone (Allo) and PG, also activate autophagy in cultured mouse astrocytes through modulation of intracellular Zn2+. Exposure of astrocytes to 250nM Allo or 500nM PG caused cytosolic vacuoles to appear within a few hours of treatment onset. Live-cell confocal microscopy of astrocytes transfected with red fluorescent protein-conjugated LC3 (RFP-LC3), a marker for autophagic vacuoles (AVs), as well as transmission electron microscopy, revealed that these vacuoles were AVs. In addition, Western blots showed increases in LC3-II levels. Interestingly, mTOR and Akt were concurrently activated, and their blockade further increased LC3-II levels and caused some cell death. These results indicate that co-activation of mTOR and Akt may act to limit neurosteroid-induced autophagy and thus inhibit autophagic cell death. As in other cases of autophagy, cellular Zn2+ levels increased after treatment with neurosteroids. The neurosteroid-induced increase in LC3-II levels was inhibited by addition of the Zn2+ chelator TPEN. Both the increase in LC3-II levels and activation of Akt and mTOR by neurosteroids were all mediated by PG receptors, as the effects were blocked by the addition of RU-486, a PG receptor antagonist. Moreover, mutant huntingtin (mHtt) aggregates in GFP-mHttQ74-transfected astrocytes were substantially reduced by neurosteroid treatment, indicating that neurosteroid-induced autophagy may be functional. Present results demonstrate that Allo and PG activate autophagy in astrocytes. Notably, unlike several other autophagy inducers that, in excess, may cause autophagic cell death, Allo and PG are relatively non-toxic, possibly because of concurrent Akt and mTOR activation. Thus, as natural endogenous brain substances, Allo and PG may have a potential as therapeutic agents in neurodegenerative condition